Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04585542 · ClinicalTrials.gov registry record · Phase 4
Comparison of Potassium Binders in the ER
A Phase 4 study, sponsored by University of California, Irvine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
NCT04585542 is a Phase 4 study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 37 participants.
The verdict
NCT04585542, a Phase 4 study, was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
Study Summary
Compare efficacy of 3 oral potassium binders (cation exchange resins) on lowering blood potassium, in hospital patients with acute hyperkalemia.
Interventions
- DRUG Polyethylene Glycol 3350
- DRUG Patiromer
- DRUG Sodium zirconium cyclosilicate
- DRUG Sodium Polystyrene Sulfonate Oral Suspension [SPS]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2025-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04585542
The ClinicalTrials.gov registry entry for NCT04585542 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Polyethylene Glycol 3350 is the first listed.
NCT04585542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04585542 about?
NCT04585542 is a clinical study titled "Comparison of Potassium Binders in the ER". Compare efficacy of 3 oral potassium binders (cation exchange resins) on lowering blood potassium, in hospital patients with acute hyperkalemia.
What is the current status of trial NCT04585542?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2020-10-20. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT04585542?
The interventions under investigation include: Polyethylene Glycol 3350 (DRUG), Patiromer (DRUG), Sodium zirconium cyclosilicate (DRUG), Sodium Polystyrene Sulfonate Oral Suspension [SPS] (DRUG).
Who is sponsoring clinical trial NCT04585542?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.